NFE2L2 and systemic lupus erythematosus: In preclinical studies, Nrf2 activators such as sulforaphane, dimethyl fumarate, and bardoxolone methyl attenuated inflammation and oxidative stress in lupus mice, as well as it reduced proteinuria and protected renal function (4).